Brokerages Set Itron, Inc. (NASDAQ:ITRI) Price Target at $139.00

Shares of Itron, Inc. (NASDAQ:ITRI) have been given a consensus recommendation of “Moderate Buy” by the fourteen ratings firms that are covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $138.10.

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. increased their target price on Itron from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Thursday, October 16th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Itron in a report on Monday, December 29th. Wall Street Zen upgraded shares of Itron from a “hold” rating to a “buy” rating in a report on Tuesday, January 6th. Zacks Research cut shares of Itron from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Finally, Johnson Rice raised Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a report on Monday, January 5th.

Insider Buying and Selling at Itron

In related news, SVP Justin K. Patrick sold 379 shares of the company’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $36,577.29. Following the completion of the sale, the senior vice president owned 20,382 shares in the company, valued at approximately $1,967,066.82. This represents a 1.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $51,729.36. Following the transaction, the senior vice president owned 19,068 shares in the company, valued at approximately $1,840,252.68. This trade represents a 2.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,971 shares of company stock valued at $286,731 in the last three months. Insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Impax Asset Management Group plc grew its stake in Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after purchasing an additional 890,040 shares during the period. Norges Bank purchased a new position in shares of Itron in the 2nd quarter worth about $71,727,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Itron by 129.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock valued at $76,713,000 after buying an additional 413,487 shares during the period. Merewether Investment Management LP increased its holdings in Itron by 1,552.7% during the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after buying an additional 282,587 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in Itron by 42.5% during the third quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock worth $75,306,000 after buying an additional 180,366 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Itron Trading Up 0.9%

ITRI opened at $99.31 on Monday. The company has a fifty day moving average price of $97.95 and a two-hundred day moving average price of $117.17. Itron has a 1-year low of $90.11 and a 1-year high of $142.00. The company has a market cap of $4.55 billion, a P/E ratio of 17.86, a price-to-earnings-growth ratio of 0.55 and a beta of 1.49. The company has a current ratio of 2.17, a quick ratio of 1.91 and a debt-to-equity ratio of 0.46.

Itron (NASDAQ:ITRI) last issued its earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.48 by $0.06. Itron had a return on equity of 17.82% and a net margin of 10.69%.The company had revenue of $581.63 million during the quarter, compared to the consensus estimate of $578.49 million. During the same period last year, the business posted $1.84 EPS. The firm’s revenue for the quarter was down 5.5% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. Analysts predict that Itron will post 5.33 EPS for the current fiscal year.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.